Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.
Fiche publication
Date publication
août 2016
Journal
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Auteurs
Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel, Pr OLLAND Anne
Tous les auteurs :
Garelli E, Renaud S, Falcoz PE, Weingertner N, Olland A, Santelmo N, Massard G
Lien Pubmed
Résumé
The management of pIIIA-N2 non-small-cell lung cancer (NSCLC) is still controversial. In particular, there are wide variations in overall survival (OS), suggesting the existence of subgroups among N2 patients. We aimed to evaluate the prognostic value of microscopic pN2 in NSCLC.
Référence
Eur J Cardiothorac Surg. 2016 Aug;50(2):322-8